{"id":24,"date":"2025-10-06T17:53:48","date_gmt":"2025-10-06T08:53:48","guid":{"rendered":"https:\/\/site.convention.co.jp\/actajasthcc2026\/?page_id=24"},"modified":"2026-06-08T14:30:34","modified_gmt":"2026-06-08T05:30:34","slug":"abstract","status":"publish","type":"page","link":"https:\/\/site.convention.co.jp\/actajasthcc2026\/abstract\/","title":{"rendered":"Call for Abstract"},"content":{"rendered":"
\t\t\t

Note<\/h2>\n

12th Asian Conference on Tumor Ablation (ACTA 2026)\/ Japan Association of Systemic Therapy of Hepatocellular Carcinoma 2026 (JAST-HCC International Symposium 2026\uff09invites the submission of abstracts for oral and poster presentations.
\nAll abstracts must be submitted in English via the online submission system.<\/p>\n<\/div>\n\t\t<\/div>

\t\t\t

Abstract Submission Period<\/h2>\n

June 8 (Mon), 2026 \u2013 July 15 (Wed), 2026 at 12:00 PM(JST)<\/p>\n<\/div>\n\t\t<\/div>

\t\t\t

Presentation Style\/Categories<\/h2>\n

Presentation style<\/h3>\n

1)Symposium(ACTA)
\n2)Free Papre-Oral(ACTA)
\n3)Free Paper-Poster(ACTA)
\n4)Free Papre-Oral(JAST-HCC)
\n5)Free Paper-Poster(JAST-HCC)<\/p>\n

The presentation style will be decided by the Congress President based on the review results.<\/p>\n<\/div>\n\t\t<\/div>

\t\t\t

Session category (Symposium(ACTA))<\/h3>\n

Special Topics<\/h4>\n
<\/p>\n\n\n\n\n\n\n
1<\/th>\nSystemic chemotherapy combined width locoregional therapy<\/td>\n<\/tr>\n
2<\/th>\nEducation in Tumor Ablation<\/td>\n<\/tr>\n
3<\/th>\nApplications of AI in Tumor Ablation<\/td>\n<\/tr>\n
4<\/th>\nNew Technologies & Devices<\/td>\n<\/tr>\n
5<\/th>\nUpdates of Tumor Ablation in Asia & Oceania<\/td>\n<\/tr>\n<\/table>\n

<\/div>\n

Liver<\/h4>\n
<\/p>\n\n\n\n\n\n
1<\/th>\nAdvanced Imaging Application in HCC Ablation<\/td>\n<\/tr>\n
2<\/th>\nTechnical Tips for HCC ablation<\/td>\n<\/tr>\n
3<\/th>\nAblation for Metastatic Liver Tumors<\/td>\n<\/tr>\n
4<\/th>\nEffective Strategies for Challenging Cases in Liver<\/td>\n<\/tr>\n<\/table>\n

<\/div>\n

Organs Except for Liver<\/h4>\n
<\/p>\n\n\n\n\n\n\n\n
1<\/th>\nAblation for Lung Cancer<\/td>\n<\/tr>\n
2<\/th>\nAblation for Breast Cancer<\/td>\n<\/tr>\n
3<\/th>\nAblation for Thyroid Nodules and Cancer<\/td>\n<\/tr>\n
4<\/th>\nAblation for Bone Tumors<\/td>\n<\/tr>\n
5<\/th>\nAblation for RCC\/Adrenal Masses \/Prostate Cancer<\/td>\n<\/tr>\n
6<\/th>\nAblation for Other Organs<\/td>\n<\/tr>\n<\/table>\n

<\/div>\n

Specific Topics<\/h4>\n
<\/p>\n\n\n\n\n\n\n
1<\/th>\nRobotic-assisted Tumor Ablation<\/td>\n<\/tr>\n
2<\/th>\nHIFU & Histotripsy<\/td>\n<\/tr>\n
3<\/th>\nEUS guided\/Transluminal Ablation<\/td>\n<\/tr>\n
4<\/th>\nIRE<\/td>\n<\/tr>\n
5<\/th>\nOther<\/td>\n<\/tr>\n<\/table>\n

<\/div>\n

Session category\uff08Free Paper(ACTA)\uff09<\/h3>\n
<\/p>\n\n\n\n\n\n\n\n\n
1<\/th>\nLiver Cancer<\/td>\n<\/tr>\n
2<\/th>\nLung Cancer<\/td>\n<\/tr>\n
3<\/th>\nBreast Cancer<\/td>\n<\/tr>\n
4<\/th>\nThyroid Nodules and Cancer<\/td>\n<\/tr>\n
5<\/th>\nBone Tumors<\/td>\n<\/tr>\n
6<\/th>\nRCC\/Adrenal Masses \/Prostate Cancer<\/td>\n<\/tr>\n
7<\/th>\nOther Organs<\/td>\n<\/tr>\n<\/table>\n

<\/div>\n<\/div>\n\t\t<\/div>

\t\t\t

Abstract Acceptance or Rejection<\/h2>\n

Please note that the acceptance or rejection of abstracts, as well as the presentation style, is at the sole discretion of the Congress President.<\/p>\n<\/div>\n\t\t<\/div>

\t\t\t

Abstract Format<\/h2>\n
<\/p>\n\n\n\n
Title<\/th>\nWithin 30 words <\/td>\n<\/tr>\n
Length<\/th>\nWithin 300 words (including spaces)<\/td>\n<\/tr>\n<\/table>\n

<\/div>\n

Please note that the abstract will be published as submitted. We kindly ask you to carefully check for any typographical or grammatical errors before submission.<\/p>\n<\/div>\n\t\t<\/div>

\t\t\t

Ethical and Scientific Considerations<\/h2>\n

All studies involving human subjects or animals must have received appropriate ethical approval at the respective institution.
\nCase reports should ensure patient anonymity.
\nThe presenting author must disclose any Conflict of Interest (COI) relevant to the submitted work at the time of conference presentation.<\/p>\n<\/div>\n\t\t<\/div>

\t\t\t

Abstract Submission<\/h2>\n

You may revise or delete your submitted abstract as many times as necessary before the submission deadline.
\nPlease note that no changes can be made after the deadline.
\nTo change or update your registration information, please click the \u201cConfirmation \/ Modification\u201d button.<\/p>\n<\/div>\n\t\t<\/div><\/div><\/div>

\t\t\t

Abstract Submission<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\t\t\t

Confirmation \/ Modification<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div><\/div>

\t\t\t

This system is confirmed to work with Google Chrome, Microsoft Edge, and Safari.
Please do not use any other browser.
Safari is supported on version 2.0.3 (417.9.2) or later. Older versions are not compatible.<\/p>\n<\/div>\n\t\t<\/div>

\t\t\t

Inquiries<\/h2>\n

Congress Secretariat<\/h3>\n

12th Asian Conference on Tumor Ablation (ACTA 2026)
\nJapan Association of Systemic Therapy of Hepatocellular Carcinoma 2026
\n(JAST-HCC International Symposium 2026\uff09
\nEmail: actajasthcc2026@convention.co.jp<\/p>\n<\/div>\n\t\t<\/div>